KalVista Pharmaceuticals
KALV
KALV
138 hedge funds and large institutions have $616M invested in KalVista Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 55 increasing their positions, 31 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.95% less ownership
Funds ownership: 110.46% → 109.51% (-0.95%)
4% less capital invested
Capital invested by funds: $640M → $616M (-$24.9M)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
138
Holding in Top 10
5
Calls
$12.4M
Puts
$1.04M
Top Buyers
| 1 | +$11.1M | |
| 2 | +$3.71M | |
| 3 | +$3.13M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.96M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$2.7M |
Top Sellers
| 1 | -$8.45M | |
| 2 | -$5.78M | |
| 3 | -$5.34M | |
| 4 |
AI
Allostery Investments
Stamford,
Connecticut
|
-$5.11M |
| 5 |
JP Morgan Chase
New York
|
-$4.64M |